FX & CFD trading involves significant risk
European stocks rose after falling for the first week in more than a month, as carmakers and technology companies gained. U.S. Index futures and Asian shares declined.
The Stoxx Europe 600 Index climbed 0.2 percent to 303.85 at 11:57 a.m. in Frankfurt. European stocks fell last week as investors debated when the Federal Reserve will scale back monetary stimulus, while a report showed Chinese manufacturing unexpectedly shrank.
The volume of shares changing hands in Stoxx 600 companies was 50 percent lower than the average of the last 30 days
Fiat, Italy's largest carmaker, climbed 3.4 percent to 5.61 euros, its highest price since August 2011. The Italian government will ask Chief Executive officer Sergio Marchionne what it "can do to let the carmaker keep its plants in Italy," Industry Minister Flavio Zanonato said in a television interview with Sky Tg24. "We should find a way to match Fiat's interest with the country's," he said.
Club Mediterranee soared 23 percent to 17.03 euros, its biggest gain on record. The French all-inclusive tour operator said it received a takeover bid from management and its two largest shareholders, Axa Private Equity and Fosun International Ltd. (656), that values the company at 540 million euros ($699 million).
SAP AG (SAP) added 2.3 percent to 60 euros. The world's largest maker of business-management software has ended discussions to acquire Jive Software Inc. (JIVE), which has a market value of more than $1 billion, people familiar with the matter said.
Commerzbank AG advanced 3.3 percent to 7.92 euros. Shares in Germany's second-biggest lender have fallen 26 percent this year. Equinet Bank AG upgraded its rating on the stock to buy from sell.
FTSE 100 6,654.34 -42.45 -0.63%
CAC 40 3,981.84 +25.05 +0.63%
DAX 8,345.84 +40.52 +0.49%
|remaining time till the new event being published|
All posted material is a marketing communication solely for informational purposes and reliance on this may lead to loss. Past performance is not a reliable indicator of future results. Please read our full disclaimer.